Investors

Our strong product focus sets us apart, as does our concentration on Theramers^® - polymers with therapeutic properties. Rimon is developing a robust product pipeline with lead products that address the unmet needs in sizeable markets. The ability to develop therapeutic products for these markets, within significantly shorter timelines, represents a considerable opportunity for investment. Key near-term milestones will drive value creation, and the diversity of the product pipeline mitigates product development risk.

Rimon Therapeutics offers:

• Proprietary technology platform
• Leadership focused on value creation
• Long-term vision supported by a strong technology brand
• Access to the scientific and clinical resources of a major health sciences centre
• Demonstrated ability to leverage financial support

"Rimon Therapeutics represents an opportunity to invest in a new therapeutic paradigm. Success of any one of Rimon's products translates into substantial IRRs for existing and new investors."
Richard McCrae, Executive Chairman, Director